Hemoglobin levels and new-onset heart failure in the community

American Heart Journal

Volumn 169, Issue 1, 2015, Pages 94-101.e2

  Klip, Ijsbrand T ^a   Postmus, Douwe ^a   Voors, Adriaan A ^a   Brouwers, Frank P J ^a   Gansevoort, Ron T ^a   Bakker, Stephan J L ^a   Hillege, Hans L ^a   De Boer, Rudolf A ^a   Van Der Harst, Pim ^a   Van Gilst, Wiek H ^a   Van Veldhuisen, Dirk J ^a   Van Der Meer, Peter ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN;

ADULT; AGED; ANEMIA; ARTICLE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; COHORT ANALYSIS; DISEASE SEVERITY; FEMALE; HEART FAILURE; HEMOGLOBIN BLOOD LEVEL; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; BLOOD; RISK FACTOR;

ADULT; AGED; COHORT STUDIES; FEMALE; HEART FAILURE; HEMOGLOBINS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; RISK FACTORS;

EID: 84925883468     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2014.09.010     Document Type: Article

References (29)

1. Lawler PR, Filion KB, Dourian T, et al. Anemia and mortality in acute coronary syndromes: a systematic review and meta-analysis. Am Heart J 2013;165:143-153.e5.
2. Kengne AP, Czernichow S, Hamer M, et al. Anaemia, haemoglobin level and cause-specific mortality in people with and without diabetes. PLoS One 2012;7:e41875.
3. Groenveld HF, Januzzi JL, Damman K, et al. Anemia and mortality in heart failure patients a systematic review and meta-analysis. J Am Coll Cardiol 2008;52:818-27.
4. Foley RN, Parfrey PS, Harnett JD, et al. The impact of anemia on cardiomyopathy, morbidity, and and mortality in end-stage renal disease. Am J Kidney Dis 1996;28:53-61.
5. Sarnak MJ, Tighiouart H, Manjunath G, et al. Anemia as a risk factor for cardiovascular disease in The Atherosclerosis Risk in Communities (ARIC) study. J Am Coll Cardiol 2002;40:27-33.
6. Sandgren PE, Murray AM, Herzog CA, et al. Anemia and new-onset congestive heart failure in the general Medicare population. J Card Fail 2005;11:99-105.
7. Hillege HL, Fidler V, Diercks GF, et al. Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation 2002;106:1777-82.
8. Matsushita K, Mahmoodi BK, Woodward M, et al. Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate. JAMA 2012;307: 1941-51.
9. Smilde TD, Asselbergs FW, Hillege HL, et al. Mild renal dysfunction is associated with electrocardiographic left ventricular hypertrophy. Am J Hypertens 2005;18:342-7.
10. Statistics Netherlands. http://www.cbs.nl/en-GB/menu/home/ default.htm?Languageswitch=on. [data specifically requested] (20 February 2013).
11. Brouwers FP, de Boer RA, van der Harst P, et al. Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND. Eur Heart J 2013;34:1424-31.
12. McMurray JJ, Adamopoulos S, Anker SD, et al. ESC Committee for Practice Guidelines. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 2012;33:1787-847.
13. Linssen GC, Bakker SJ, Voors AA, et al. N-terminal pro-B-type natriuretic peptide is an independent predictor of cardiovascular morbidity and mortality in the general population. Eur Heart J 2010;31:120-7.
14. Skinner CJ, Holt D, Smith TM. Editors: analyses of complex surveys. Chichester: John Wiley and Sons; 1989. p. 195-8.
15. Royston P, Ambler G, Sauerbrei W. The use of fractional polynomials to model continuous risk variables in epidemiology. Int J Epidemiol 1999;28:964-74.
16. Putter H, Fiocco M, Geskus RB. Tutorial in biostatistics: competing risks and multi-state models. Stat Med 2007;26:2389-430.
17. Butler J, Kalogeropoulos A, Georgiopoulou V, et al. Study. Incident heart failure prediction in the elderly: the health ABC heart failure score. Circ Heart Fail 2008;1:125-33.
18. Kannel WB, D'Agostino RB, Silbershatz H, et al. Profile for estimating risk of heart failure. Arch Intern Med 1999;159:1197-204.
19. Varat MA, Adolph RJ, Fowler NO. Cardiovascular effects of anemia. Am Heart J 1972;83:415-26.
20. Metivier F, Marchais SJ, Guerin AP, et al. Pathophysiology of anaemia: focus on the heart and blood vessels. Nephrol Dial Transplant 2000;15(Suppl 3):14-8.
21. Gagnon DR, Zhang TJ, Brand FN, et al. Hematocrit and the risk of cardiovascular disease-the Framingham study: a 34-year follow-up. Am Heart J 1994;127:674-82.
22. Kunnas T, Solakivi T, Huuskonen K, et al. Hematocrit and the risk of coronary heart disease mortality in the TAMRISK study, a 28-year follow-up. Prev Med 2009;49:45-7.
23. Sorlie PD, Garcia-Palmieri MR, Costas Jr R, et al. Hematocrit and risk of coronary heart disease: the Puerto Rico Health Program. Am Heart J 1981;101:456-61.
24. Madsen PL, Scheuermann Freestone M, Neubauer S, et al. Haemoglobin and flow-mediated vasodilation. Clin Sci (Lond) 2006;110:467-73.
25. Natali A, Toschi E, Baldeweg S, et al. Haematocrit, type 2 diabetes, and endothelium-dependent vasodilatation of resistance vessels. Eur Heart J 2005;26:464-71.
26. Coglianese EE, Qureshi MM, Vasan RS, et al. Usefulness of the blood hematocrit level to predict development of heart failure in a community. Am J Cardiol 2012;109:241-5.
27. Holsworth R, Jr Cho Y, Weidman JJ, et al. Cardiovascular benefits of phlebotomy: relationship to changes in hemorheological variables. Perfusion 2014;29:102-16.
28. Meyers DG, Jensen KC, Menitove JE. A historical cohort study of the effect of lowering body iron through blood donation on incident cardiac events. Transfusion 2002;42:1135-9.
29. Velagaleti RS, Gona P, Larson MG, et al. Multimarker approach for the prediction of heart failure incidence in the community. Circulation 2010;122:1700-6.